Timothy S. Pardee

4.7k total citations
98 papers, 2.2k citations indexed

About

Timothy S. Pardee is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Timothy S. Pardee has authored 98 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Hematology, 47 papers in Molecular Biology and 30 papers in Oncology. Recurrent topics in Timothy S. Pardee's work include Acute Myeloid Leukemia Research (53 papers), Cancer, Hypoxia, and Metabolism (22 papers) and Acute Lymphoblastic Leukemia research (17 papers). Timothy S. Pardee is often cited by papers focused on Acute Myeloid Leukemia Research (53 papers), Cancer, Hypoxia, and Metabolism (22 papers) and Acute Lymphoblastic Leukemia research (17 papers). Timothy S. Pardee collaborates with scholars based in United States, United Kingdom and Belgium. Timothy S. Pardee's co-authors include Heidi D. Klepin, Bayard L. Powell, Leslie R. Ellis, Janet A. Tooze, Stephen B. Kritchevsky, Jeff D. Williamson, Alfred S. Ponticelli, Ann M. Geiger, Scott Isom and Chaitanya Bangur and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Timothy S. Pardee

92 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy S. Pardee United States 26 1.1k 924 546 422 357 98 2.2k
Florian H. Heidel Germany 30 1.7k 1.5× 1.8k 1.9× 509 0.9× 195 0.5× 268 0.8× 143 3.1k
Gwen Nichols United States 24 1.1k 1.0× 504 0.5× 1.1k 2.0× 209 0.5× 113 0.3× 63 2.4k
Jacqueline M. Lafky United States 24 385 0.3× 151 0.2× 1.1k 2.1× 226 0.5× 110 0.3× 60 2.0k
Jae‐Yong Kwak South Korea 21 233 0.2× 303 0.3× 398 0.7× 125 0.3× 120 0.3× 115 1.3k
Chih‐Fen Huang Taiwan 21 539 0.5× 577 0.6× 204 0.4× 155 0.4× 136 0.4× 55 1.3k
Josef Thaler Austria 24 593 0.5× 599 0.6× 885 1.6× 86 0.2× 116 0.3× 108 2.0k
Young Joo Min South Korea 28 1.0k 0.9× 346 0.4× 1.4k 2.6× 560 1.3× 114 0.3× 106 2.7k
David L. DeRemer United States 17 310 0.3× 258 0.3× 295 0.5× 87 0.2× 110 0.3× 64 1.1k
Krish Patel United States 20 540 0.5× 94 0.1× 514 0.9× 146 0.3× 27 0.1× 105 1.7k
Mamdooh Gari Saudi Arabia 20 738 0.7× 701 0.8× 232 0.4× 230 0.5× 159 0.4× 69 1.7k

Countries citing papers authored by Timothy S. Pardee

Since Specialization
Citations

This map shows the geographic impact of Timothy S. Pardee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy S. Pardee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy S. Pardee more than expected).

Fields of papers citing papers by Timothy S. Pardee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy S. Pardee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy S. Pardee. The network helps show where Timothy S. Pardee may publish in the future.

Co-authorship network of co-authors of Timothy S. Pardee

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy S. Pardee. A scholar is included among the top collaborators of Timothy S. Pardee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy S. Pardee. Timothy S. Pardee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klepin, Heidi D., Janet A. Tooze, W. Jack Rejeski, et al.. (2025). Pilot study of an inpatient physical activity intervention for older adults treated intensively for acute myeloid leukemia. Blood Advances. 9(20). 5152–5163.
2.
Rodríguez‐Arbolí, Eduardo, GL Phillips, Timothy S. Pardee, Hillard M. Lazarus, & Robert Peter Gale. (2025). Intensive post-remission therapy does not decrease relapse after allotransplants for acute myeloid leukaemia in 1st remission and should not be given. Leukemia. 39(5). 1053–1055. 1 indexed citations
3.
Anderson, Rebecca G., Lance D. Miller, Scott Isom, et al.. (2022). Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia. Nature Communications. 13(1). 1673–1673. 28 indexed citations
4.
Pardee, Timothy S., Susan Lyerly, Sarah Dralle, et al.. (2020). Frontline Selinexor and Chemotherapy Is Highly Active in Older Adults with Acute Myeloid Leukemia (AML). Blood. 136(Supplement 1). 24–25. 4 indexed citations
5.
Alexander, Peter, et al.. (2020). The Novel Phospholipid Mimetic KPC34 Is Highly Active Against Acute Myeloid Leukemia with Activated Protein Kinase C. Translational Oncology. 13(7). 100780–100780. 1 indexed citations
6.
7.
8.
9.
Pardee, Timothy S., Rebecca G. Anderson, Scott Isom, et al.. (2018). A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia. Clinical Cancer Research. 24(9). 2060–2073. 80 indexed citations
10.
Anderson, Rebecca G., et al.. (2018). Mitochondria in cancer metabolism, an organelle whose time has come?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1870(1). 96–102. 50 indexed citations
11.
Pardee, Timothy S., Scott Isom, Leslie R. Ellis, et al.. (2017). Interim Analysis of a Single Arm Phase II Study of Cpi-613 in Combination with High Dose Cytarabine and Mitoxantrone for Patients with Relapsed or Refractory AML. Blood. 130. 2626–2626. 1 indexed citations
12.
13.
Lycan, Thomas, Timothy S. Pardee, W. Jeffrey Petty, et al.. (2016). A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma. PLoS ONE. 11(10). e0164244–e0164244. 49 indexed citations
14.
Pardee, Timothy S., King Lee, John Luddy, et al.. (2014). A Phase I Study of the First-in-Class Antimitochondrial Metabolism Agent, CPI-613, in Patients with Advanced Hematologic Malignancies. Clinical Cancer Research. 20(20). 5255–5264. 91 indexed citations
15.
16.
Caudell, David L., et al.. (2014). The Efficacy of the Ribonucleotide Reductase Inhibitor Didox in Preclinical Models of AML. PLoS ONE. 9(11). e112619–e112619. 8 indexed citations
17.
Pardee, Timothy S., Johannes Zuber, & Scott W. Lowe. (2011). Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner. Experimental Hematology. 39(4). 473–485.e4. 22 indexed citations
18.
Pardee, Timothy S., Denise Levitan, & David D. Hurd. (2011). Altered mitochondrial metabolism as a target in acute myeloid leukemia.. Journal of Clinical Oncology. 29(15_suppl). 6590–6590. 7 indexed citations
19.
Pardee, Timothy S., et al.. (2006). Effective CD34+ stem cell mobilization with low-dose pegfilgrastim. Journal of Applied Research. 6(3). 196–200. 3 indexed citations
20.
Ponticelli, Alfred S., Timothy S. Pardee, & Kevin Struhl. (1995). The Glutamine-Rich Activation Domains of Human Sp1 Do Not Stimulate Transcription in Saccharomyces cerevisiae. Molecular and Cellular Biology. 15(2). 983–988. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Florian H. Heidel Breakdown of academic impact, for papers by Gwen Nichols Breakdown of academic impact, for papers by Jacqueline M. Lafky Breakdown of academic impact, for papers by Jae‐Yong Kwak Breakdown of academic impact, for papers by Chih‐Fen Huang Breakdown of academic impact, for papers by Josef Thaler Breakdown of academic impact, for papers by Young Joo Min Breakdown of academic impact, for papers by David L. DeRemer Breakdown of academic impact, for papers by Krish Patel Breakdown of academic impact, for papers by Mamdooh Gari
Rankless by CCL
2026